๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Actavis Group hf โ€” Licensed Medicines

35 medicines held by Actavis Group hf on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 35 products held by Actavis Group hf
MedicineActive substanceLicence holderStatus
Actelsar HCT 40 mg/12.5 mg tablets
EU/1/13/817/001-013
Hydrochlorothiazide, Telmisartan Actavis Group hf โ€”
Actelsar HCT 80 mg/12.5 mg tablets
EU/1/13/817/014-028
Hydrochlorothiazide, Telmisartan Actavis Group hf โ€”
Actelsar HCT 80 mg/25 mg tablets
EU/1/13/817/029-041
Hydrochlorothiazide, Telmisartan Actavis Group hf โ€”
Armisarte 25 mg/ml concentrate for solution for infusion
EU/1/15/1063/001-004
Pemetrexed diacid Actavis Group hf โ€”
Desloratadine Actavis 5 mg film-coated tablets
EU/1/11/745/001-009
Desloratadine Actavis Group hf โ€”
Ebilfumin 30 mg hard capsules
EU/1/14/915/001-002
Oseltamivir phosphate Actavis Group hf โ€”
Ebilfumin 45 mg hard capsules
EU/1/14/915/003-004
Oseltamivir phosphate Actavis Group hf โ€”
Ebilfumin 75 mg hard capsules
EU/1/14/915/005-006
Oseltamivir phosphate Actavis Group hf โ€”
Levetiracetam Actavis 1000 mg film-coated tablets
EU/1/11/713/031-040
Levetiracetam Actavis Group hf โ€”
Levetiracetam Actavis 250 mg film-coated tablets
EU/1/11/713/001-010
Levetiracetam Actavis Group hf โ€”
Levetiracetam Actavis 500 mg film-coated tablets
EU/1/11/713/011-020
Levetiracetam Actavis Group hf โ€”
Levetiracetam Actavis 750 mg film-coated tablets
EU/1/11/713/021-030
Levetiracetam Actavis Group hf โ€”
Levetiracetam Actavis Group 100 mg/ml oral solution
EU/1/11/738/001-003
Levetiracetam Actavis Group hf โ€”
Nemdatine 10 mg film-coated tablets
EU/1/13/824/003-010
Memantine hydrochloride Actavis Group hf โ€”
Nemdatine 15 mg film-coated tablets
EU/1/13/824/011-013
Memantine hydrochloride Actavis Group hf โ€”
Nemdatine 20 mg film-coated tablets
EU/1/13/824/014-017
Memantine hydrochloride Actavis Group hf โ€”
Nemdatine 5 mg film-coated tablets
EU/1/13/824/001-002
Memantine hydrochloride Actavis Group hf โ€”
Nemdatine 5 mg, 10 mg, 15 mg, 20 mg film-coated tablets
EU/1/13/824/018
Memantine hydrochloride, Memantine hydrochloride, Memantine hydrochloride, Memantine hydrochloride Actavis Group hf โ€”
Pioglitazone Actavis 15 mg tablets
EU/1/12/755/001-009
Pioglitazone hydrochloride Actavis Group hf โ€”
Pioglitazone Actavis 30 mg tablets
EU/1/12/755/010-018
Pioglitazone hydrochloride Actavis Group hf โ€”
Pioglitazone Actavis 45 mg tablets
EU/1/12/755/019-027
Pioglitazone hydrochloride Actavis Group hf โ€”
Potactasol 1 mg powder for concentrate for solution for infusion
EU/1/10/660/001
Topotecan hydrochloride Actavis Group hf โ€”
Potactasol 4 mg powder for concentrate for solution for infusion
EU/1/10/660/002
Topotecan hydrochloride Actavis Group hf โ€”
Rapilysin 10 U powder and solvent for solution for injection.
EU/1/96/018/001
Reteplase Actavis Group hf โ€”
Rivastigmine Actavis 1.5 mg hard capsules
EU/1/11/693/001-004
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 3 mg hard capsules
EU/1/11/693/005-008
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 4.5 mg hard capsules
EU/1/11/693/009-012
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 6 mg hard capsules
EU/1/11/693/013-016
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Sildenafil Actavis 100 mg film-coated tablets
EU/1/09/595/11-15
Sildenafil Actavis Group hf โ€”
Sildenafil Actavis 25 mg film-coated tablets
EU/1/09/595/1-5
Sildenafil Actavis Group hf โ€”
Sildenafil Actavis 50 mg film-coated tablets
EU/1/09/595/6-10
Sildenafil Actavis Group hf โ€”
Telmisartan Actavis 20 mg tablets
EU/1/10/639/001-010
Telmisartan Actavis Group hf โ€”
Telmisartan Actavis 40 mg tablets
EU/1/10/639/011-020
Telmisartan Actavis Group hf โ€”
Telmisartan Actavis 80 mg tablets
EU/1/10/639/021-030
Telmisartan Actavis Group hf โ€”
Zoledronic acid Actavis 4 mg/5 ml concentrate for solution for infusion
EU/1/12/759/001-003
Zoledronic acid monohydrate Actavis Group hf โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.